Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial

Author:Kern, Drew   Dashtipour, Khashayar   Aldred, Jason   Kimber, Thomas   Iansek, Robert   Kukreja, Pavnit   Bergmann, Lars   Fisseha, Nahome   Gupta, Resmi   Talapala, Saritha   Jeong, Anna   Fung, Victor   Lepetit, Vincent   

Session Name:S32: Movement Disorders: Trials  

Topic:Movement Disorders  

Program Number:S32.004  

Author Institution:University of Colorado Anschutz Medical Campus, Aurora, CO  Loma Linda University, Loma Linda, CA  Selkirk Neurology & Inland Northwest Research, Spokane, WA  Department of Neurology Unit, Royal Adelaide Hospital  Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia  Monash Health, Melbourne, Australia  AbbVie Inc., North Chicago, IL  AbbVie Inc., Ludwigshafen, Germany  Movement Disorders Unit, Westmead Hospital  Sydney Medical School, University of Sydney , Sydney, Australia  

MGBase: The launch of an international electronic database for patients with Myasthenia Gravis

Author:Reddel, Stephen   Barnett Tapia, Carolina   Butzkueven, Helmut   Buzzard, Katherine   Cutter, Gary   Kaminski, Henry   Van Der Walt, Anneke   zhang, wen wen   

Session Name:P7: Neuromuscular Disease: Neuromuscular Junction Disorders 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.014  

Author Institution:Sydney Neurology, Campberdown, Australia  University of Toronto, Toronto, ON, Canada  Monash Health, Melbourne, Australia  Eastern Health, Dept Neuroscience, Box Hill, Australia  University of Alabama At Birmingham, Birmingham, AL  George Washington University, Washington, DC  Melbourne Health, Kew, Australia  Alfred Health, Melbourne, Australia